Literature DB >> 11522852

Mycophenolate mofetil: implications for the treatment of glomerular disease.

C Badid1, A Desmouliere, M Laville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11522852     DOI： 10.1093/ndt/16.9.1752

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  [41-year-old female patient with ST-elevation myocardial infarction and multiple arterial emboli].

Authors:  J Bramstedt; J Schröder; R Dissmann
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

2.  Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

Authors:  M Chiara; E Menegatti; D Di Simone; A Davit; D Bellis; D Sferch; G De Rosa; O Giachino; L M Sena; D Roccatello
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 3.  Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Authors:  Ali Sahin
Journal:  Eurasian J Med       Date:  2009-12

4.  Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.

Authors:  Jutta Gellermann; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2004-01       Impact factor: 3.714

Review 5.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.